Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation

R. O. Perez, A. Habr-Gama, G. P. São Julião, I. Proscurshim, C. R. Ono, P. Lynn, P. Bailão Aguilar, S. C. Nahas, J. Gama-Rodrigues, C. A. Buchpiguel

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Aim:Inguinal nodes may be a possible route for lymphatic spread in patients with distal rectal cancer. The outcome was examined for patients with distal rectal cancer undergoing neoadjuvant chemoradiation (CRT) and having 2-fluorine-18-fluoro-2-deoxy-d-glucose (FDG)-avid inguinal nodes using positron emission tomography/computed tomography (PET/CT) imaging. Method: Ninety-nine consecutive patients with cT2-4N0-2M0 distal rectal adenocarcinoma were enrolled in a clinical trial (NCT00254683) and underwent baseline PET/CT followed by 54 Gy and 5-fluorouracil-based CRT. After CRT, patients underwent 6-and 12-week PET/CT. Patients with positive inguinal node uptake were compared with patients with negative uptake.The inguinal region was not included in the field of radiation therapy. Results: Seventeen (17%) patients had baseline positive inguinal node FDG uptake. They were more likely to have the tumour closer to the anal verge (2.0 vs 4.2 cm; P = 0.001). Of these, eight (47%)demonstrated a positive inguinal uptake at PET/CT after 12 weeks from CRT. Patients with inguinal node FDG uptake after CRT (positive PET at baseline and 12 weeks) had a significantly worse 3-year overall and disease-free survival (P = 0.02 and P = 0.03). After a median follow-up period of 22 months, none of these patients had developed inguinal recurrence. Conclusion: Uptake of inguinal nodes at PET/CT may be present in up to 17% of patients with distal rectal cancer, particularly with ultra-low tumours. Nearly half of these nodes no longer show uptake after CRT despite the groin area not being included in the radiation field. Persistence of inguinal node uptake 12 weeks after CRT completion may be a marker for worse oncological outcome. Colorectal Disease

Original languageEnglish (US)
Pages (from-to)674-682
Number of pages9
JournalColorectal Disease
Issue number6
StatePublished - Jun 2013

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this